Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial

Nobuaki Matsubara, Ronald de Wit, Arjun Vasant Balar, Arlene O. Siefker‐Radtke, Jakub Żołnierek, Tibor Csőszi, Sang Joon Shin, Se Hoon Park, Vagif Atduev, Mahmut Gümüş, Yu‐Li Su, Saziye Burcak Karaca, Hernán Cutuli, Mehmet Alı Nahıt Şendur, Liji Shen, Karen O’Hara, Chinyere E. Okpara, Sonia Franco, Blanca Homet Moreno, Petros Grivas, Yohann Loriot